News

Following recent approvals in the EU, US and China, the Singapore approval is based on two replicate phase 3 studies that showed Dupixent achieved significant reduction in exacerbations, and also ...
FDA approves Dupixent as the first new CSU treatment in over a decade. 2. Phase 3 trial shows significant symptom reduction ...
Asthma biologics can be continued and initiated during conception, throughout pregnancy and while breastfeeding, especially ...
That gives it an advantage over other biologics for severe asthma, such as Sanofi/Regeneron's IL-4/IL-13 inhibitor Dupixent (dupilumab ... has attributed to complex administration and a demanding ...
the US FDA has approved Sanofi and Regeneron's Dupixent (dupilumab) for COPD - as has China's National Medical Products Administration (NMPA), which announced its approval the same day.
swallowed topical corticosteroids taken after meals with a 30 min fasting period and dupilumab administered subcutaneously once a week). Etrasimod's simple administration, independent of meals, could ...
The FDA granted Priority Review to lenacapavir for the prevention of HIV as pre-exposure prophylaxis (PrEP). Lenacapavir is a long-acting HIV-1 capsid inhibitor administered as a twice-yearly ...
New biologic and targeted therapies are changing the landscape of prurigo nodularis care, offering sustained relief and ...
Current eosinophilic esophagitis treatment guidelines include dietary modifications, medications, and endoscopic procedures.
In a letter, Harvard’s president pointed to areas of agreement with the Trump administration, including a need for more “intellectual diversity.” He also argued Harvard is not partisan.
Former New Hampshire Gov. Chris Sununu (R) said Sunday that the Trump administration has “about six weeks” when it comes to a China tariff deal to give the market and small businesses ...
The Trump administration on Monday asked the Supreme Court to allow it to resume the deportations of nearly 200 Venezuelan migrants detained in Texas, requesting that the court lift its order from ...